Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Artivion logo — Pioneering Heart and Vascular Health with Advanced Surgical...

Artivion

Pioneering Heart and Vascular Health with Advanced Surgical Solutions and Biomaterials for All Ages

Founded 1984 Post Ipo Debt Total: $451.25M Hardware, Health Care

General Information

Company Name Artivion
Founded Year 1984
Founders / Decision Makers
Team member Team member Team member Team member
Industries Hardware, Health Care
Funding Stage Post Ipo Debt
Social

Get notified when Artivion moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Artivion

Artivion is a medical device company founded in 1984 which focuses on pioneering heart and vascular health through advanced surgical solutions and biomaterials. The company's flagship products include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch tissue, both processed with the SynerGraft technology. In addition, they offer a range of surgical adhesives, sealants, and hemostats such as BioGlue, BioFoam, PerClot, and HemoStase. In January 2024, Ares Management made a $350.00M post-IPO debt investment in Artivion, reflecting a strong investor interest. Despite the absence of specific headquarter information, Artivion's notable success in the Hardware and Health Care industries signifies its potential for growth and innovation.

Taxonomy: biological medical devices, surgical adhesives, biomaterials, cardiac reconstruction, vascular reconstruction, implantable devices, human tissue preservation, CryoValve SG pulmonary heart valve, CryoPatch SG pulmonary cardiac patch tissue, SynerGraft technology, BioGlue Surgical Adhesive, BioFoam Surgical Matrix, PerClot, HemoStase, Starch Medical Inc

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1
Investor
18 Jan 2024
Post-IPO Debt •••••• - 18 Jun 2020
Post-IPO Equity •••••• - 12 Oct 2010

Artivion Alternatives & Competitors

Artivion vs
Uscom
Uscom Australia

Practice-changing, non-invasive cardiovascular and pulmonary devices.

44 employees
Biotechnology, Health Care
Artivion vs
Topanga Terrace
Topanga Terrace

Comprehensive care for every step of your recovery journey—from joint replacements to cardiac and st...

30 employees
Health Care
Artivion vs
Tennova Healthcare- Turkey Creek Medical Center
Tennova Healthcare- Turkey Creek Medical Center United States

Providing compassionate care to the Farragut and surrounding communities.

145 employees

FAQ About Artivion

Pioneering Heart and Vascular Health with Advanced Surgical Solutions and Biomaterials for All Ages
Artivion was founded in 1984.
Artivion operates in the following industries: Hardware, Health Care.
Artivion has completed 3 funding rounds, raising a total of $451.25M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Artivion include Uscom, Topanga Terrace, Tennova Healthcare- Turkey Creek Medical Center, TARA Biosystems, CARDIVA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Artivion and Uscom are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Artivion and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes